Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
104.00    -0.50 (-0.48%)
Bid:
103.50
Ask:
105.50
Spread: 2.00 (1.932%)
Market Cap: £303.92m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

Directorate Change

28 Jan 2022 07:00

RNS Number : 8813Z
Big Technologies PLC
28 January 2022
 

28 January 2022

 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group")

 

Appointment of Independent Non-Executive Director 

 

Big Technologies plc, the UK-based remote people monitoring technology company, is pleased to announce that Alexander Brennan will be appointed as a non-executive Director of the Company with effect from the 1st February 2022.

 

Alexander has nearly two decades' experience of delivering growth for businesses in the UK and internationally, both as principal and as an advisor. Alexander founded Brennan & Partners in 2016, a UK-headquartered consultancy, providing business development advisory services for UK and international clients. Prior to this, Alexander worked at De La Rue Plc for five years, focusing on B2G and B2B sales across Europe and the Americas. Alexander began his career at Slaughter and May where he practised as a corporate and M&A lawyer for six years.

 

Following Alexander's appointment, the Board will comprise Simon Collins (Non-Executive Chairman), Sara Murray OBE (CEO), Daren Morris (CFO), Charles Lewinton (CTO), Camila Macun and Alexander Brennan (Non-Executive Directors).

 

Sara Murray OBE, Chief Executive Officer, commented:

 

"We are delighted that Alex is joining us and look forward to his contribution to the development of the Group, adding further independent experience and a history of successful business development in international markets."

 

Simon Collins, Non-Executive Chairman, commented:

"At the time of our admission to AIM in July last year, we committed to appoint an additional independent non-executive director to the board. I am pleased to welcome Alex to strengthen the balance of the board and confirm our commitment to the governance principles set out in the QCA Code."

 

In accordance with Schedule 2(g) of the AIM Rules for Companies, Alexander Manuel Philip Martin Brennan (aged 41) holds, or has held in the past five years, the following directorships and partnerships:

 

Current Directorships

Directorships held in last 5 years

Brennan & Partners Limited

38 Draycott Place Freehold Company Limited

 

Alexander holds no shares in the Company.

 

 

There is no further information on Alexander Brennan required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

 

 

 

For further information please contact:

Big Technologies plc +44 (0) 19 2360 1910

 

Sara Murray (Chief Executive Officer)

Daren Morris (Chief Financial Officer)

 

Zeus Capital (Nominated Adviser and Sole Broker) +44 (0) 20 3829 5000

 

Jamie Peel (Corporate Finance)

Dan Bate (Corporate Finance)

Benjamin Robertson (Equity Capital Markets)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUUPGUPPGPM
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
30th Mar 20267:00 amRNSAudited Results for the year to 31 December 2025
26th Feb 20267:00 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBoard Changes
2nd Feb 20267:00 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSFurther Litigation Update
10th Dec 20259:41 amRNSHolding(s) in Company
9th Dec 20259:42 amRNSHolding(s) in Company
8th Dec 20257:00 amRNSTrading Update
3rd Nov 20252:54 pmRNSDirector and PDMR Dealings
16th Oct 20257:01 amRNSWithdrawal of General Meeting Requisition Notice
16th Oct 20257:00 amRNSBoard Changes
3rd Oct 20257:00 amRNSBoard Changes
30th Sep 20257:00 amRNSInterim Results for the 6 months to 30 June 2025
26th Sep 20257:00 amRNSNotice of Requisition of a General Meeting
12th Sep 20257:00 amRNSLitigation Update
20th Aug 20257:00 amRNSChange of Website Address
6th Aug 20257:00 amRNSBoard Change and Issue of Shares
1st Aug 20257:00 amRNSIssue of Shares
28th Jul 20257:00 amRNSBoard Changes
22nd Jul 20257:00 amRNSTrading Update
18th Jun 20252:53 pmRNSResult of AGM and Litigation Update
13th Jun 20258:12 amRNSPublication of Letter to Shareholders
10th Jun 20251:27 pmRNSSuspension of Voting Rights and Letter Response
5th Jun 20257:00 amRNSLitigation Update
22nd May 20259:45 amRNSDirector Dealings
22nd May 20257:00 amRNS2024 Audited Results and Notice of AGM
16th May 20257:00 amRNSAppointment of Joint Corporate Broker
8th May 20257:00 amRNSBoard and Management Changes and Trading Update
7th Apr 20257:00 amRNSAppointment of Non Executive Director
3rd Apr 20257:00 amRNSUpdate re: CEO Dismissal
1st Apr 20257:00 amRNS-RContract Award
1st Apr 20257:00 amRNSDirectorate Change
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20255:20 pmRNSCEO Dismissal and Commencement of Litigation
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 202511:13 amRNSLitigation Update
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 202512:51 pmRNSCEO Suspension
18th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.